Singapore, Mar 15, 2010: German drug behemoth Bayer Schering is strengthening its employee base in India and Vietnam to gain market share in two of Asia's fastest growing pharma markets.

Alok Kanti, regional head, Bayer Schering Pharma Asia Pacific said, "We see above average growth rates in the economies of Asia Pacific compared to the global average, and at the same time, currently we see a lower than average usage of healthcare expenditures in these areas. So when you combine these two, you get a disproportionate opportunity for healthcare in Asia Pacific."

Bayer has fledgling operation in these two countries

Richard Nieman, Head of Global Medical Affairs Asia, Bayer Schering Pharma Asia Pacific, said, "We have a number of trials going on; we have a study going on in Vietnam regarding our liver cancer drug, which is an important study to be doing, involving Vietnamese patients."